-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Australian 62-year-old amyotrophic lateral sclerosis (ALS) patient Philip O'Keefe recently became the first person to post a message on social media using only his own thoughts
O'Keefe's technology for sending messages was developed by the brain-computer interface company Synchron, and the device is called the Stentrode brain-computer interface (SBCI): an intravascular brain implant
This tiny (8mm) brain implant is designed to allow people who have lost the ability to speak to communicate using only their thoughts
Like other ALS patients, O'Keefe developed progressive paralysis that left him unable to speak earlier this year
O'Keefe used the account of Synchron CEO Thomas Oakley to tweet his history-making news
O'Keefe expressed hope that the SBCI program in which he is a part will help pave the way for new technologies to regain independence for those who have lost the ability to speak or move
Synchron said it plans to expand SBCI to include developing devices that can be used to diagnose and even treat conditions such as Parkinson's, high blood pressure, epilepsy and even depression
Editor-in-Chief
Editor-in-ChiefThe concept of brain-computer interface has existed for a long time, but it was not until the 1990s that there were phased results